CureVac is a biotechnology company that is active in the field of messenger RNA (mRNA) technology. Using mRNA it is able to directly give the body the information it needs to fight disease. CureVac mainly focuses on three therapeutic areas: cancer immunotherapies, prophylactic vaccines, and protein delivery.
CureVac total Funding
CureVac latest funding size
Time since last funding
|a year ago|
|Qatar Investment Authority, Baillie Gifford, DH Capital, Bill & Melinda Gates Foundation, OH Beteiligungen, dievini Hopp Biotech Holding, Baden-Württembergische Versorgungsanstalt für Ärzte, Chartwave, Coppel Family, Landeskreditbank Baden-Württemberg, LBBW Asset Management, Northview LifeSciences, Sigma Group, The European Commission|
Revenue growth (FY, 2017 - FY, 2018), %
Gross profit (FY, 2018)
Gross profit margin (FY, 2018), %
Net income (FY, 2018)
|Company Name||Date||Deal Size|
|CureVac Real Estate GmbH|
CureVac revenue breakdown by business segment: 37.3% from Goods Deliveries and 62.7% from Services
CureVac revenue breakdown by geographic segment: 78.3% from Foreign and 21.7% from Germany
CureVac has 5 Twitter Followers. The number of followers has increased 344.4% quarter over quarter
When was CureVac founded?
CureVac was founded in 2000.
Who are CureVac key executives?
CureVac's key executives are Ingmar Hoerr, Franz-Werner Haas and Florian von der Mulbe.
How many employees does CureVac have?
CureVac has 400 employees.
What is CureVac revenue?
Latest CureVac annual revenue is €12.6 m.
What is CureVac revenue per employee?
Latest CureVac revenue per employee is €31.4 k.
Who are CureVac competitors?
Competitors of CureVac include Stemirna, RNACure and RNAimmune.
Where is CureVac headquarters?
CureVac headquarters is located at Friedrich-Miescher-Straße 15, Tübingen.
Where are CureVac offices?
CureVac has offices in Tübingen, Frankfurt am Main and Boston.
How many offices does CureVac have?
CureVac has 4 offices.
Receive alerts for 300+ data fields across thousands of companies